三世情缘

多特声明:“50+1规则”是德国足球核心支柱,契合会员主导的文化_我的网站

拜托小姐

一 |     8月26日讯 新赛季德甲即将开启之际,多特俱乐部再次重申了对“50+1规则”的支持。

二 | 在官方声明中,多特写道:在第64个德甲赛季即将开启之际,多特及其球迷认为有必要特别强调联邦卡特尔局针对“50+1规则”所作出的裁决。经过长达多年的程序,联邦卡特尔局原则上认定“50+1规则”具有合法性。在2026年8月19日举行的上一次球迷委员会会议上,大家对这一决定进行了深入讨论,并一致对联邦卡特尔局的原则性评估表示明确欢迎。自1998年引入以来,“50+1规则”始终是德国职业足球的核心支柱,它契合由会员主导的俱乐部文化与可持续的经济模式,构成了德甲在国际对比中脱颖而出的独特性基础。    Shares of Pfizer are in retreat on the first day of trading after the drug company said sales of its COVID-19 vaccine and its coronavirus treatment are weaker than it had expected and cut revenue projections by $9 billion for the year. Falling sales of both clipped sales in the second quarter, but Pfizer said in August that it expected a rebound in the second half of 2023. Shares of Pfizer slipped more than 1% before the opening bell Monday and Moderna, which is heavily reliant on the competing vaccine it makes, slid nearly 5%. Pfizer said Friday that global usage of Paxlovid is trending slightly above last year, but that it's still below expectations.The fall vaccination period just began and the New York City drugmaker said that it's too soon to get a handle on vaccination rates for the year.Full-year revenue for Paxlovid and Comirnaty is expected to be approximately $12.5 billion, short $9 billion of what it had expected. Pfizer is lowering its full-year revenue expectations for Paxlovid by approximately $7 billion. That number also accounts for delayed commercialization of the product, which was pushed to January 2024 from the company's previous expectation of commercialization in the second half of this year. Pfizer is also lowering its 2023 revenue expectations for Comirnaty by approximately $2 billion due to lower-than-expected vaccination rates.Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1.45 and $1.65 per share due to lower-than-anticipated revenue for COVID-19-related products and inventory write-offs.That is short of the full-year revenue of $63.61 billion and earnings of $2.77 per share that Wall Street was expecting, and far short of the company's previous projections of per-share earning between $3.25 and $3.45. JPMorgan said the company's update solves an ongoing U.S. Paxlovid inventory debate and it anticipates the company's bigger-than-expected cuts to its sales projections will help put a floor under per-share earnings expectations for next year.。

三 | 多特及其球迷坚定支持“50+1规则”并主张长期保留该规则。因此,我们对联邦卡特尔局的原则性评估表示明确欢迎。我们坚信,只有通过这种方式才能确保德国足球的长期成功,这也正是多特早在许多年前就将该原则牢牢写入俱乐部章程及核心价值守则的原因。

Current article:http://3eg.cousizhegaobaolengkuo.bond/iwfrys/20260826/2774098.html

Published on:01:54:39


我的网站最近更新

我的网站热门资讯